OxSyBio Overview

  • Founded
  • 2014
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

OxSyBio General Information


Developer of 3D printing techniques designed to produce a range of tissue-like and functional tissues for medical research and clinical applications. The company's 3D printing techniques include developing a method of printing tissue-like materials comprised of 3-dimensional networks of lipid monolayer aqueous droplets, that are capable of conducting electrical signals along pre-defined pathways and self-folding to form complex geometries, enabling users to access a range of applications in regenerative medicine and synthetic biology.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Printing Services (B2B)
Primary Office
  • The Walbrook Building
  • 25 Walbrook
  • London EC4N 8AF
  • England, United Kingdom
+44 0113 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OxSyBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Oct-2019 000.00 Completed Out of Business
2. Early Stage VC 16-Jul-2018 000.00 000.00 000.00 Completed Generating Revenue
1. Early Stage VC 11-Nov-2015 $1.54M $1.54M 00.000 Completed Generating Revenue
To view OxSyBio’s complete valuation and funding history, request access »

OxSyBio Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preference 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
A Ordinary 3,134 $0.002643 $210.83 $210.83 1x $210.83 11.05%
Ordinary 5,240 $0.013215 $132.15 $132.15 1x $132.15 18.47%
To view OxSyBio’s complete cap table history, request access »